Journal for ImmunoTherapy of Cancer (Nov 2023)
796 Pegylated liposomal doxorubicin chemotherapy, Flt3 ligand, and CD40 agonist triplet combination improves tumor control in breast cancers
Abstract
No abstracts available.
Journal for ImmunoTherapy of Cancer (Nov 2023)